Phase Forward, Inc. (NASDAQ:PFWD)

CAPS Rating: 2 out of 5

A provider of integrated enterprise-level software products, services and hosted solutions for use in its customers' global clinical trial and drug safety monitoring activities.

Recs

0
Player Avatar stefancasemyr (< 20) Submitted: 9/3/2009 12:40:29 PM : Outperform Start Price: $13.27 PFWD Score: -4.49

Market leader,

Featured Broker Partners


Advertisement